GR3026478T3 - Peptides with organo-protective activity, process for their preparation and their use in the therapy. - Google Patents

Peptides with organo-protective activity, process for their preparation and their use in the therapy.

Info

Publication number
GR3026478T3
GR3026478T3 GR980400664T GR980400664T GR3026478T3 GR 3026478 T3 GR3026478 T3 GR 3026478T3 GR 980400664 T GR980400664 T GR 980400664T GR 980400664 T GR980400664 T GR 980400664T GR 3026478 T3 GR3026478 T3 GR 3026478T3
Authority
GR
Greece
Prior art keywords
peptides
organo
therapy
preparation
protective activity
Prior art date
Application number
GR980400664T
Other languages
English (en)
Inventor
Marijan Mr Sc Petek
Sven Seiwerth
Predrag Dr Sc Sikiric
Zeljko Grabarevic
Ivo Mr Sc Rotkvic
Marko Duvnjak
Branko Turkovic
Stjepan Mr Sc Mise
Ernest Dr Sc Suchanek
Boris Mildner
Ivan Udovicic
Original Assignee
Petek Marijan
Sven Seiwerth
Sikiric Predrag
Zeljko Grabarevic
Rotkvic Ivo
Marko Duvnjak
Branko Turkovic
Stjepan Mr Sc Mise
Suchanek Ernest
Boris Mildner
Ivan Udovicic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Petek Marijan, Sven Seiwerth, Sikiric Predrag, Zeljko Grabarevic, Rotkvic Ivo, Marko Duvnjak, Branko Turkovic, Stjepan Mr Sc Mise, Suchanek Ernest, Boris Mildner, Ivan Udovicic filed Critical Petek Marijan
Publication of GR3026478T3 publication Critical patent/GR3026478T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR980400664T 1992-11-16 1998-03-27 Peptides with organo-protective activity, process for their preparation and their use in the therapy. GR3026478T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR921283 1992-11-16
PCT/EP1993/003217 WO1994011394A2 (en) 1992-11-16 1993-11-16 Peptides with organo-protective activity, process for their preparation and their use in the therapy

Publications (1)

Publication Number Publication Date
GR3026478T3 true GR3026478T3 (en) 1998-06-30

Family

ID=10945833

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400664T GR3026478T3 (en) 1992-11-16 1998-03-27 Peptides with organo-protective activity, process for their preparation and their use in the therapy.

Country Status (17)

Country Link
EP (1) EP0624164B1 (el)
JP (1) JP2812803B2 (el)
AT (1) ATE163131T1 (el)
AU (1) AU5624994A (el)
BG (1) BG61697B1 (el)
CA (1) CA2127553C (el)
CZ (1) CZ285155B6 (el)
DE (1) DE69316974T2 (el)
ES (1) ES2114170T3 (el)
GR (1) GR3026478T3 (el)
HU (3) HUT66303A (el)
PL (1) PL304666A1 (el)
RO (1) RO115733B1 (el)
RU (1) RU2116311C1 (el)
SI (1) SI9300595B (el)
SK (1) SK279227B6 (el)
WO (1) WO1994011394A2 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL132884A0 (en) * 1997-05-23 2001-03-19 Sikiric Predrag Body protection compound peptide salts with organo-protective activity pharmaceutical and diagnostic compositions containing the same the use thereof and process for preparing the same
SI24318A (sl) * 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU176089A (sh) * 1989-09-12 1992-09-07 Sikirić, Predrag Postupak za pripremu supstancije bpc i supstancija bpc
ATE152734T1 (de) * 1992-05-30 1997-05-15 Sikiric Predrag Bpc-peptide, deren herstellung und verwendung

Also Published As

Publication number Publication date
SK85794A3 (en) 1995-01-12
HUT67982A (en) 1995-05-29
HU9401952D0 (en) 1994-09-28
PL304666A1 (en) 1995-01-09
HU9303247D0 (en) 1994-03-28
BG61697B1 (bg) 1998-03-31
DE69316974D1 (de) 1998-03-19
CZ285155B6 (cs) 1999-05-12
EP0624164B1 (en) 1998-02-11
BG98907A (bg) 1995-05-31
EP0624164A1 (en) 1994-11-17
JP2812803B2 (ja) 1998-10-22
CA2127553C (en) 2003-01-28
CA2127553A1 (en) 1994-05-26
WO1994011394A3 (en) 1994-09-15
WO1994011394A2 (en) 1994-05-26
SK279227B6 (sk) 1998-08-05
RU2116311C1 (ru) 1998-07-27
DE69316974T2 (de) 1998-07-16
ES2114170T3 (es) 1998-05-16
HU211260A9 (en) 1995-11-28
RO115733B1 (ro) 2000-05-30
CZ162294A3 (en) 1995-02-15
AU5624994A (en) 1994-06-08
SI9300595B (sl) 2003-04-30
SI9300595A (en) 1994-09-30
JPH07507568A (ja) 1995-08-24
HUT66303A (en) 1994-11-28
ATE163131T1 (de) 1998-02-15
RU94037232A (ru) 1996-06-20

Similar Documents

Publication Publication Date Title
CA2223433A1 (en) Ob protein compositions and methods
EP0726706A4 (en) N, N 'DISUBSTITUTED GUANIDINES AND THEIR USE AS EXCITATOR AMINO ACID ANTAGONISTS
NZ210194A (en) Pentapeptides with thymopoietin and splenin like activity
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
GR3024379T3 (en) Peptides with organo-protective activity, the process for preparing them and their use in therapy
CA2105552A1 (en) Soluble ligands for cd40
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
CA2147623A1 (en) Novel p-selectin ligand protein
TW364850B (en) Nematocidal compositions
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
CA2186423A1 (en) Protein which induces interferon-gamma production by immunocompetent cell
NZ222466A (en) Hexa to deca peptides capable of stimulating the proliferation of myelopoietic stem cells
HU895788D0 (en) Process for producing peptides and medical products containing them
WO1995030001A3 (en) Novel p-selectin ligand protein
GR3026478T3 (en) Peptides with organo-protective activity, process for their preparation and their use in the therapy.
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
MY105110A (en) Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
EP0254905A3 (en) Shiga vaccine
NZ505350A (en) DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours
EP1688431A3 (en) Analogs of thymosin alpha 1
ZA867783B (en) Mitogenic peptides
BG102974A (en) Ethene-containing solutions and their use in methods of treatment or prevention
IL91848A0 (en) Human amino acid transporters,diagnostic compositions and methods for detecting cancer utilizing the same
NZ329694A (en) Use of isolated cytolytic T cell clone specific for a complex of HLA-A2 and a peptide which complexes with HLA-A2 to treat cancer